120 related articles for article (PubMed ID: 16625041)
1. External beam radiotherapy boosts to reduce the impact caused by edema in prostate permanent seed implants.
Yue N; Mori J; Nath R; Heron DE; Huq MS
Phys Med Biol; 2006 May; 51(9):2267-77. PubMed ID: 16625041
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumor repopulation on radiotherapy planning.
Wang JZ; Li XA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
[TBL] [Abstract][Full Text] [Related]
3. Prescription dose in permanent (131)Cs seed prostate implants.
Yue N; Heron DE; Komanduri K; Huq MS
Med Phys; 2005 Aug; 32(8):2496-502. PubMed ID: 16193779
[TBL] [Abstract][Full Text] [Related]
4. Prostate gland edema after single-fraction high-dose rate brachytherapy before external beam radiation therapy.
Cury FL; Duclos M; Aprikian A; Patrocinio H; Souhami L
Brachytherapy; 2010; 9(3):208-12. PubMed ID: 20149758
[TBL] [Abstract][Full Text] [Related]
5. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer.
Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J
Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446
[TBL] [Abstract][Full Text] [Related]
6. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
Wang JZ; Mayr NA; Nag S; Montebello J; Gupta N; Samsami N; Kanellitsas C
Med Phys; 2006 Apr; 33(4):1025-32. PubMed ID: 16696479
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose.
Wang JZ; Li XA
Med Phys; 2003 Jan; 30(1):34-40. PubMed ID: 12557976
[TBL] [Abstract][Full Text] [Related]
9. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
10. Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging.
Sloboda RS; Usmani N; Pedersen J; Murtha A; Pervez N; Yee D
Brachytherapy; 2010; 9(4):354-61. PubMed ID: 20116344
[TBL] [Abstract][Full Text] [Related]
11. Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy.
Al-Salihi O; Mitra A; Payne H
Prostate Cancer Prostatic Dis; 2006; 9(4):370-3. PubMed ID: 16832383
[TBL] [Abstract][Full Text] [Related]
12. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
Yue N; Chen Z; Nath R
Phys Med Biol; 2002 Apr; 47(7):1185-204. PubMed ID: 11996063
[TBL] [Abstract][Full Text] [Related]
13. A mathematical approach for evaluating the influence of dose heterogeneity on TCP for prostate cancer brachytherapy treatment.
Strigari L; Orlandini LC; Andriani I; d'Angelo A; Stefanacci M; Di Nallo AM; Benassi M
Phys Med Biol; 2008 Sep; 53(18):5045-59. PubMed ID: 18723926
[TBL] [Abstract][Full Text] [Related]
14. A simple method for dose fusion from multimodality treatment of prostate cancer: brachytherapy to external beam therapy.
Cao M; Ko SC; Slessinger ED; DesRosiers CM; Johnstone PA; Das IJ
Brachytherapy; 2011; 10(3):214-20. PubMed ID: 20843747
[TBL] [Abstract][Full Text] [Related]
15. Potential impact of prostate edema on the dosimetry of permanent seed implants using the new 131Cs (model CS-1) seeds.
Chen Z; Deng J; Roberts K; Nath R
Med Phys; 2006 Apr; 33(4):968-75. PubMed ID: 16696473
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of clinically localized prostate cancer. Part III--external beam radiotherapy].
Gisterek I; Szelachowska J; Kornafel J
Pol Merkur Lekarski; 2006 Dec; 21(126):602-6. PubMed ID: 17405307
[TBL] [Abstract][Full Text] [Related]
17. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
[TBL] [Abstract][Full Text] [Related]
18. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
19. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric effects of patient rotational setup errors on prostate IMRT treatments.
Fu W; Yang Y; Li X; Heron DE; Huq MS; Yue NJ
Phys Med Biol; 2006 Oct; 51(20):5321-31. PubMed ID: 17019041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
